September 2019 FDA Recall Drug by Gcp Laboratories Inc
D-0126-2020 - Microbial Contamination of Non-Sterile Product.
This Class II drug recall was voluntarily initiated by Gcp Laboratories Inc on September 18, 2019 for the product Drug. The FDA reported the reason for recall as microbial contamination of non-sterile product.. The product was distributed Nationwide and the recall is currently terminated.
Recall Number: D-0126-2020
Microbial Contamination of Non-Sterile Product.
09-18-2019
10-16-2019
31,392 30 mL bottles
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
GCP Laboratories Inc
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
Distributed in MI and further distributed Nationwide.
02-05-2021
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
Major Infants' Gas Relief Drops, Simethicone Oral Suspension USP, 1 FL OZ (30 mL) bottle, Distributed by: Major Pharmaceuticals 17177 N Laurel Park Drive, Suite 233 Livonia, MI 48152 USA. NDC 0904-5894-30
Batch or Lot Expiration Information
Lot# Lot: WBD003 Exp. 03/21